Palisade Bio (PALI) Amortization of Deferred Charges (2013 - 2017)
Palisade Bio (PALI) posted quarterly Amortization of Deferred Charges of $12127.0 for Q2 2017, down 15.57% year-over-year from $14363.0 in Q2 2016, and down 74.55% quarter-over-quarter from $47654.0 in Q1 2017.
Powered by 
Analysis
Palisade Bio (PALI) Amortization of Deferred Charges (2013 - 2017) Analysis & Trends
Palisade Bio (PALI) has reported Amortization of Deferred Charges for 3 consecutive years, with $12127.0 the latest figure, recorded in Q2 2017.
- In Q2 2017, Amortization of Deferred Charges fell 15.57% year-over-year to $12127.0; the TTM figure through Dec 2017 stood at $59781.0 (down 82.8% YoY), while the FY2017 annual figure was $59781.0, down 82.8% from the prior year.
- Amortization of Deferred Charges fell to $12127.0 in Q2 2017 per PALI's latest filing, from $47654.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $221494.0 in Q3 2015 and bottomed at $12127.0 in Q2 2017.
- Historically, Amortization of Deferred Charges has averaged $105525.8 across 3 years, with a median of $71833.0 in 2016.
- On a YoY basis, Amortization of Deferred Charges climbed as much as 15.57% in 2017 and fell as far as 74.85% in 2017.
- Palisade Bio's Amortization of Deferred Charges stood at $215440.0 in 2015, then tumbled by 70.29% to $63998.0 in 2016, then slumped by 81.05% to $12127.0 in 2017.
- Business Quant data shows PALI's Amortization of Deferred Charges at $12127.0 in Q2 2017, $47654.0 in Q1 2017, and $63998.0 in Q4 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Palisade Bio | 440.73 Mn | 315.53 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2017 | 12,127.00 |
| Mar 31, 2017 | 47,654.00 |
| Dec 31, 2016 | 63,998.00 |
| Sep 30, 2016 | 79,668.00 |
| Jun 30, 2016 | 14,363.00 |
| Mar 31, 2016 | 189,462.00 |
| Dec 31, 2015 | 215,440.00 |
| Sep 30, 2015 | 221,494.00 |
| Jun 30, 2015 | 218,414.00 |
| Mar 31, 2015 | 215,182.00 |
| Dec 31, 2014 | 207,388.00 |
| Sep 30, 2014 | 190,136.00 |
| Jun 30, 2014 | 207,313.00 |
| Mar 31, 2014 | 224,795.00 |
| Dec 31, 2013 | 231,381.00 |
| Sep 30, 2013 | 223,672.00 |
| Jun 30, 2013 | 216,219.00 |
| Mar 31, 2013 | 22,903.00 |